US Stock MarketDetailed Quotes
NEPH Nephros
- 1.855
- -0.005-0.27%
Close Aug 28 16:00 ET
19.56MMarket Cap-15458P/E (TTM)
1.895High1.780Low5.55KVolume1.820Open1.860Pre Close10.26KTurnover0.10%Turnover RatioLossP/E (Static)10.54MShares4.04352wk High2.47P/B10.47MFloat Cap1.35052wk Low--Dividend TTM5.64MShs Float11.666Historical High--Div YieldTTM6.16%Amplitude0.905Historical Low1.849Avg Price1Lot Size
Nephros Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -321.68%-501K | -343.48%-672K | 125.57%827K | -21.54%-237K | 430.59%562K | 121.08%226K | 115.36%276K | -128.23%-3.23M | 41.79%-195K | 81.32%-170K |
| Net income from continuing operations | 33.26%-289K | 44.77%-169K | 77.84%-1.58M | 22.88%-654K | 94.23%-182K | 61.92%-433K | 84.44%-306K | -83.76%-7.11M | 18.62%-848K | -171.43%-3.15M |
| Operating gains losses | ---7K | ---3K | ---- | ---- | ---- | ---- | ---- | 87.47%-60K | --0 | --0 |
| Depreciation and amortization | -33.96%35K | -37.04%34K | -39.03%214K | -7.27%51K | -44.00%56K | -49.04%53K | -41.30%54K | 39.29%351K | -38.89%55K | 88.68%100K |
| Other non cash items | ---- | 43.68%125K | ---- | ---- | ---- | ---- | 1.16%87K | ---- | ---- | ---- |
| Change In working capital | -153.10%-257K | -2,432.26%-723K | 92.13%830K | -150.12%-210K | -8.06%525K | 311.35%484K | 109.42%31K | -51.08%432K | 41,800.00%419K | 339.92%571K |
| -Change in receivables | -193.02%-360K | 96.75%-22K | -161.90%-221K | -156.82%-50K | -84.26%119K | 146.35%387K | -294.54%-677K | 228.42%357K | 201.15%88K | 539.53%756K |
| -Change in inventory | -163.59%-131K | -153.50%-382K | -49.41%387K | -216.37%-391K | -134.98%-142K | 568.18%206K | 965.67%714K | 158.45%765K | 242.37%336K | 15.34%406K |
| -Change in prepaid assets | 44.00%36K | -790.00%-69K | 115.38%56K | 2,150.00%41K | 56.52%-20K | -77.88%25K | 125.64%10K | 116.67%26K | 98.73%-2K | -276.92%-46K |
| -Change in payables and accrued expense | 129.26%67K | -276.62%-136K | 186.00%639K | 1,164.29%149K | 218.01%642K | -152.64%-229K | 112.42%77K | -162.86%-743K | -102.51%-14K | -51.11%-544K |
| -Change in other current assets | 53.57%258K | 283.33%11K | -197.64%-373K | -672.34%-538K | -96.74%3K | -12.50%168K | -250.00%-6K | --382K | 571.43%94K | 9,100.00%92K |
| -Change in other current liabilities | -73.97%-127K | -43.68%-125K | 196.34%342K | 797.59%579K | 17.20%-77K | 18.89%-73K | 2.25%-87K | -7.90%-355K | 6.74%-83K | -9.41%-93K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -321.68%-501K | -343.48%-672K | 125.57%827K | -21.54%-237K | 430.59%562K | 121.08%226K | 115.36%276K | -128.23%-3.23M | 41.79%-195K | 81.32%-170K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 45.26%-75K | -75K | 0 | -61.18%-137K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | 45.26%-75K | ---75K | --0 | ---- | ---- | -280.56%-137K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | 45.26%-75K | ---75K | --0 | ---- | ---- | -61.18%-137K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0.00%-2K | 97.30%-2K | -332.35%-79K | 97.30%-3K | 0 | 97.01%-2K | -126.33%-74K | -85.65%34K | -200.00%-111K | -250.00%-69K |
| Net issuance payments of debt | 0.00%-2K | 97.30%-2K | 72.38%-79K | 96.25%-3K | --0 | 97.01%-2K | -5.71%-74K | -8.33%-286K | -23.08%-80K | -1.47%-69K |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -67.47%163K | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --157K | ---31K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 0.00%-2K | 97.30%-2K | -332.35%-79K | 97.30%-3K | --0 | 97.01%-2K | -126.33%-74K | -85.65%34K | -200.00%-111K | -250.00%-69K |
| Net cash flow | ||||||||||
| Beginning cash position | -5.29%3.63M | 18.52%4.31M | -47.88%3.63M | 17.31%4.62M | -2.85%4.06M | -29.24%3.84M | -47.88%3.63M | -15.47%6.97M | -46.39%3.94M | -49.52%4.18M |
| Current changes in cash | -346.88%-553K | -433.66%-674K | 120.17%673K | -2.94%-315K | 335.15%562K | 118.04%224K | 113.03%202K | -163.79%-3.34M | 17.74%-306K | 74.19%-239K |
| Effect of exchange rate changes | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 81.82%-2K | --0 | --0 |
| End cash Position | -24.14%3.08M | -5.29%3.63M | 18.52%4.31M | 18.52%4.31M | 17.31%4.62M | -2.85%4.06M | -29.24%3.84M | -47.88%3.63M | -47.88%3.63M | -46.39%3.94M |
| Free cash flow | -346.02%-556K | -343.48%-672K | 122.31%752K | -60.00%-312K | 430.59%562K | 119.23%226K | 115.07%276K | -132.00%-3.37M | 41.79%-195K | 81.58%-170K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg